Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

  • News

Executive Summary

Church & Dwight flat in Q3

You may also be interested in...



New Products In Brief

Listerine line extension zeroes out alcohol: Johnson & Johnson formulates its Listerine Zero mouthwash with four essential oils but no alcohol. The product claims to kill germs and freshen breath with a formula less intense than other antiseptics. Listerine Zero, in Clean Mint flavor, launched Aug. 4 across food, drug and mass merchandise outlets, in four stock-keeping units ranging from 250 mL to 1.5 L. Suggested retail prices are from $3.89 to $8.49, J&J says

SCOLR Ready To Answer FDA Questions On 12-Hour Pseudoephedrine ANDA

FDA has raised questions on "minor" issues regarding SCOLR Pharma's proposed nonprescription 12-hour pseudoephedrine tablet, according to the firm

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Table

View full table

Topics

Tags:
OTC Drugs
UsernamePublicRestriction

Register

PS104683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By